If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoats Group Plc Regulatory News (COA)

Share Price Information for Coats Group Plc (COA)

Share Price is delayed by 15 minutes
Get Live Data
77.85    -0.75 (-0.95%)
Bid:
77.85
Ask:
78.00
Spread: 0.15 (0.193%)
Market Cap: £1.49b
COA Live PriceLast checked at - London Stock Exchange

Intraday Coats Group Plc Share Chart

Director/PDMR Shareholding

27 Sep 2023 12:32

RNS Number : 8706N
Coats Group PLC
27 September 2023
 

COATS GROUP PLC

LEI: 2138003SPYWGAITNFY17

 

27 September 2023

 

Director/PDMR shareholding

 

Coats Group plc ("Coats" or the "Company"), the world's leading industrial thread and footwear components manufacturer, was notified on 27 September 2023 that Rajiv Sharma, Chief Executive Officer and a Person Discharging Managerial Responsibilities ("PDMR"), acquired and sold ordinary shares of 5 pence each in the Company ("Shares") following the exercise of options, which included the right to dividend equivalents ("Dividend Shares"), granted under the Company's Deferred Annual Bonus Plan ("DABP") as set out below:

 

Date of Grant

Plan

Option Price

Sale Price (£)

Number of Shares acquired

Number of Dividend Shares acquired

Number of Shares sold

Number of Shares retained

28 Feb 2018

DABP

Nil cost share options

0.7405

184,542

6,835

191,377

0

4 March 2019

DABP

Nil cost share options

0.7405

162,044

6,729

168,773

 0

6 March 2020

DABP

Nil cost share options

0.7405

349,640

15,590

365,230

 0

Total

696,226

29,154

725,380

0

 

Following the above transactions, Rajiv's interest in the Company's Shares (excluding outstanding options under the Company's LTIP and DABP) is 4,596,492 Shares. This holding, and the net unvested Deferred Annual Bonus awards that are not subject to performance conditions, fulfils more than twice the requirement to have a minimum shareholding of 200% of basic salary that applies to the Chief Executive under the Company's approved Remuneration Policy.

 

This notification is made in accordance with the requirements of Article 19 of the UK Market Abuse Regulation and the Notification of Dealing Form for the PDMR can be found below.

 

Enquiry details

Investors

Victoria Huxster / Julian Wais

Coats Group plc

+44 (0)7880 471 350

Media

Richard Mountain / Nick Hasell

FTI Consulting

+44 (0)20 3727 1374

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Rajiv Sharma 

b)

Position/status

Chief Executive Officer and Executive Director

c)

Initial notification/ Amendment

Initial notification 

2

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of entity

Coats Group plc

b)

Legal Entity Identifier Code

2138003SPYWGAITNFY17

3

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of £0.05

b)

Identification code/ ISIN

GB00B4YZN328

c)

Nature of the transaction

Acquisition of Shares resulting from the exercise of options under the Coats Group plc Deferred Annual Bonus Plan (including dividend equivalents)

d)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

191,377

168,773

365,230

e)

Aggregated information- Aggregated volume- Price

 

725,380

n/a

f)

Date of the transaction

26 September 2023

g)

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Rajiv Sharma 

b)

Position/status

Chief Executive Officer and Executive Director

c)

Initial notification/ Amendment

Initial notification 

2

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of entity

Coats Group plc

b)

Legal Entity Identifier Code

2138003SPYWGAITNFY17

3

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of £0.05

b)

Identification code/ ISIN

GB00B4YZN328

c)

Nature of the transaction

Sale of Shares resulting from the exercise of options under the Coats Group plc Deferred Annual Bonus Plan (including dividend equivalents)

d)

Price(s) and volume(s)

Price(s)

Volume(s)

£0.7405

725,380

e)

Aggregated information- Aggregated volume- Price

 

725,380

£537,143.89

f)

Date of the transaction

26 September 2023

g)

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUBOAROAUKUAR
Date   Source Headline
4th Mar 20217:00 amRNS2020 Full Year Results
3rd Mar 20217:00 amRNSRemuneration and Audit Committee Changes
26th Feb 202110:52 amRNSTotal Voting Rights
2nd Feb 202111:30 amRNSHolding(s) in Company
28th Jan 202111:07 amRNSHolding(s) in Company
31st Dec 20201:31 pmRNSTotal Voting Rights
23rd Dec 20207:00 amRNSDirector/PDMR Shareholding
1st Dec 20204:05 pmRNSDirector/PDMR Shareholding
26th Nov 202011:11 amRNSDirector/PDMR Shareholding
24th Nov 20207:00 amRNSNew Chairman appointment
23rd Nov 20202:29 pmRNSHolding(s) in Company
5th Nov 202012:36 pmRNSHolding(s) in Company
3rd Nov 20207:00 amRNSTrading Statement
14th Oct 20207:00 amRNSConfirmation of CFO Designate start date
6th Oct 202011:09 amRNSBlock listing Interim Review
22nd Sep 20207:00 amRNSDirector Declaration
13th Aug 20207:00 amRNSHalf-year Report
29th Jul 20207:00 amRNSAppointment of Chief Financial Officer Designate
29th Jun 20209:25 amRNSHolding(s) in Company
11th Jun 20203:17 pmRNSResult of AGM
27th May 20204:47 pmRNSDirector/PDMR Shareholding
20th May 20207:00 amRNSTrading Statement
18th May 20202:28 pmRNSNotice of AGM
18th May 202010:03 amRNSDirectorate Change
13th May 20203:06 pmRNSNotice of AGM
28th Apr 20205:24 pmRNSHolding(s) in Company
28th Apr 20201:21 pmRNSNotice of AGM
27th Apr 20202:01 pmRNSDisclosure of rights attached to securities
23rd Apr 20201:48 pmRNSHolding(s) in Company
3rd Apr 20202:13 pmRNSBlock listing Interim Review
2nd Apr 20204:30 pmRNSHolding(s) in Company
1st Apr 20207:00 amRNSDirectorate Change
27th Mar 20207:00 amRNSTrading Statement
24th Mar 20204:19 pmRNSHolding(s) in Company
23rd Mar 20209:48 amRNSHolding(s) in Company
20th Mar 20204:45 pmRNSSecond Price Monitoring Extn
20th Mar 20204:36 pmRNSPrice Monitoring Extension
12th Mar 20202:52 pmRNSDirector/PDMR Shareholding
12th Mar 202010:46 amRNSDirector/PDMR Shareholding
11th Mar 202010:14 amRNSHolding(s) in Company
10th Mar 20201:31 pmRNSAnnual Financial Report
9th Mar 20208:13 amRNSDirector/PDMR Shareholding
6th Mar 20202:18 pmRNSDirector/PDMR Shareholding
6th Mar 20202:17 pmRNSDirector/PDMR Shareholding
6th Mar 20208:23 amRNSHolding(s) in Company
5th Mar 20207:00 amRNSFinal Results
2nd Mar 202011:03 amRNSAdditional Listing
28th Feb 20203:48 pmRNSTotal Voting Rights
14th Feb 20201:29 pmRNSHolding(s) in Company
11th Feb 20207:00 amRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.